Steven Leonard Chapman - Mar 15, 2024 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
CEO AND PRESIDENT, Director
Signature
/s/ Tami Chen, Attorney-in-Fact
Stock symbol
NTRA
Transactions as of
Mar 15, 2024
Transactions value $
-$4,772,752
Form type
4
Date filed
3/29/2024, 09:35 PM
Previous filing
Mar 7, 2024
Next filing
Apr 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Sale -$903K -10.3K -20.16% $87.98 40.6K Mar 15, 2024 By Chapman Family Trust F1, F2, F3, F4
transaction NTRA Common Stock Sale -$1.83M -20.6K -50.62% $88.97 20.1K Mar 15, 2024 By Chapman Family Trust F1, F4, F5
transaction NTRA Common Stock Sale -$1.8M -20.1K -100% $89.60 0 Mar 15, 2024 By Chapman Family Trust F1, F4, F6
transaction NTRA Common Stock Options Exercise +5.18K +2.23% 237K Mar 27, 2024 Direct F7
transaction NTRA Common Stock Sale -$241K -2.66K -1.12% $90.42 235K Mar 28, 2024 Direct F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTRA Restricted Stock Unit Options Exercise $0 -5.18K -100% $0.00* 0 Mar 27, 2024 Common Stock 5.18K Direct F7, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.4050 to $88.40 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Includes 50,910 shares previously reported as owned indirectly by the Rosewood Trust.
F4 The Reporting Person is a trustee of the Chapman Family Trust and has voting and dispositive power with respect to the reported shares. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.4050 to $89.39 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.4050 to $89.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F8 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on March 27, 2020.
F9 The RSUs vest over four years. 25% of the RSUs vested on March 27, 2021 and the remaining shares vest in 12 equal quarterly installments thereafter.